Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents

被引：303

作者：

Kumar, SK ^{[1
]}

Hager, E ^{[1
]}

Pettit, C ^{[1
]}

Gurulingappa, H ^{[1
]}

Davidson, NE ^{[1
]}

Khan, SR ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Div Expt Therapeut, Baltimore, MD 21231 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 14期

关键词：

D O I：

10.1021/jm030213+

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of boronic-chalcone derivatives were synthesized and tested for antitumor activity against human breast cancer cell lines. The results show the boronic-chalcones are more toxic to breast cancer cells compared to normal breast cells than other known chalcones.

引用

页码：2813 / 2815

页数：3

共 34 条

[31] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C
Salvi, R
Argentini, M
Dureuil, C
Delumeau, I
Abecassis, J
Debussche, L
Wasylyk, B
[J]. ONCOGENE, 1999, 18 (11) : 1921 - 1934
[32] INHIBITION OF CARCINOGEN-INDUCED PULMONARY AND MAMMARY CARCINOGENESIS BY CHALCONE ADMINISTERED SUBSEQUENT TO CARCINOGEN EXPOSURE
WATTENBERG, LW
COCCIA, JB
GALBRAITH, AR
[J]. CANCER LETTERS, 1994, 83 (1-2) : 165 - 169
[33] THE POTENT ANTI-TUMOR-PROMOTING AGENT ISOLIQUIRITIGENIN
YAMAMOTO, S
AIZU, E
JIANG, H
NAKADATE, T
KIYOTO, I
WANG, JC
KATO, R
[J]. CARCINOGENESIS, 1991, 12 (02) : 317 - 323
[34] MDM2 oncogene as a novel target for human cancer therapy
Zhang, RW
Wang, H
[J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (04) : 393 - 416

← 1 2 3 4 →